These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Genetic approaches to the study of meningococci]. Kukhtevich EV Zh Mikrobiol Epidemiol Immunobiol; 1992; (11-12):62-5. PubMed ID: 1301667 [No Abstract] [Full Text] [Related]
43. Isolation of Neisseria meningitidis strains with increase of penicillin minimal inhibitory concentrations. Sáez-Nieto JA; Fontanals D; Garcia de Jalon J; Martinez de Artola V; Peña P; Morera MA; Verdaguer R; Sanfeliu I; Belio-Blasco C; Perez-Saenz JL Epidemiol Infect; 1987 Oct; 99(2):463-9. PubMed ID: 3119361 [TBL] [Abstract][Full Text] [Related]
44. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Vienne P; Ducos-Galand M; Guiyoule A; Pires R; Giorgini D; Taha MK; Alonso JM Clin Infect Dis; 2003 Dec; 37(12):1639-42. PubMed ID: 14689345 [TBL] [Abstract][Full Text] [Related]
45. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis. Skoczynska A; Ruckly C; Hong E; Taha MK Clin Microbiol Infect; 2009 Dec; 15(12):1178-81. PubMed ID: 19456827 [TBL] [Abstract][Full Text] [Related]
46. [The serosubtyping of serogroup B meningococci]. Koroleva IS; Demina AA Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):41-4. PubMed ID: 8525731 [TBL] [Abstract][Full Text] [Related]
47. Emerging fluoroquinolone resistance in Neisseria meningitidis in India: cause for concern. Mehta G; Goyal R J Antimicrob Chemother; 2007 Feb; 59(2):329-30. PubMed ID: 17185299 [No Abstract] [Full Text] [Related]
48. First case of Neisseria meningitidis capsule null locus infection in China. Xu Z; Zhu B; Xu L; Gao Y; Shao Z Infect Dis (Lond); 2015 Aug; 47(8):591-2. PubMed ID: 25728375 [TBL] [Abstract][Full Text] [Related]
49. Have South Australian isolates of Neisseria meningitidis become less susceptible to penicillin, rifampicin and other drugs? A study of strains isolated over three decades, 1971-1999. Hansman D; Wati S; Lawrence A; Turnidge J Pathology; 2004 Apr; 36(2):160-5. PubMed ID: 15203752 [TBL] [Abstract][Full Text] [Related]
51. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Rosenstein NE; Stocker SA; Popovic T; Tenover FC; Perkins BA Clin Infect Dis; 2000 Jan; 30(1):212-3. PubMed ID: 10619761 [No Abstract] [Full Text] [Related]
52. Antibiotic susceptibility of invasive Neisseria meningitidis isolates from 1995 to 2008 in Sweden--the meningococcal population remains susceptible. Hedberg ST; Olcén P; Fredlund H; Unemo M Scand J Infect Dis; 2010; 42(1):61-4. PubMed ID: 19883157 [TBL] [Abstract][Full Text] [Related]
53. Differences in virulence for mice between disease and carrier strains of Neisseria meningitidis. Holbein BE Can J Microbiol; 1981 Jul; 27(7):738-41. PubMed ID: 6794895 [TBL] [Abstract][Full Text] [Related]
54. In silico analysis of different generation β lactams antibiotics with penicillin binding protein-2 of Neisseria meningitidis for curing meningococcal disease. Tripathi V; Tripathi P; Srivastava N; Gupta D Interdiscip Sci; 2014 Dec; 6(4):259-70. PubMed ID: 25118647 [TBL] [Abstract][Full Text] [Related]
55. Dynamics of carriage of Neisseria meningitidis in a group of military recruits: subtype stability and specificity of the immune response following colonization. Jones GR; Christodoulides M; Brooks JL; Miller AR; Cartwright KA; Heckels JE J Infect Dis; 1998 Aug; 178(2):451-9. PubMed ID: 9697726 [TBL] [Abstract][Full Text] [Related]
56. Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci. Mäkelä PH; Peltola H Lancet; 1978 Oct; 2(8093):780-1. PubMed ID: 80699 [No Abstract] [Full Text] [Related]
57. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil. Weidlich L; Baethgen LF; Mayer LW; Moraes C; Klein CC; Nunes LS; Rios Sda S; Kmetzsch CI; Rossetti ML; Zaha A J Infect; 2008 Oct; 57(4):324-31. PubMed ID: 18814914 [TBL] [Abstract][Full Text] [Related]
58. Emergence of meningococci with reduced susceptibility to third-generation cephalosporins. Deghmane AE; Hong E; Taha MK J Antimicrob Chemother; 2017 Jan; 72(1):95-98. PubMed ID: 27733517 [TBL] [Abstract][Full Text] [Related]
59. exl, an exchangeable genetic island in Neisseria meningitidis. Kahler CM; Blum E; Miller YK; Ryan D; Popovic T; Stephens DS Infect Immun; 2001 Mar; 69(3):1687-96. PubMed ID: 11179344 [TBL] [Abstract][Full Text] [Related]
60. [N. meningitidis strains isolated in Belgium between 1969 and 1972]. Gilquin-Courtois C Arch Belg Med Soc; 1973; 31(6):431-48. PubMed ID: 4205262 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]